
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Our top pick for
Cheap broker fees
Our top pick for
Best overall platform
Our top pick for
Best for US stocks
Open | $80.89 | Previous close | $81.18 |
High | $81.43 | Change | $-0.2 |
Low | $80.76 | Change % | -0.246% |
Close | $80.98 | Timestamp | 1611349200 |
Volume | N/A | GMT offset | 0 |
Standard brokerage - US shares
Important: Share trading carries risk of capital loss.
This is not a recommendation, it represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Merck & Co (MRK) is a leading Pharmaceuticals business based in the USA. Merck & Co (MRK) is listed on the NASDAQ and employs 71000 staff.
Industry | Drug Manufacturers-General | Currency symbol | $ |
Code | MRK | Country name | USA |
Type | Common Stock | Country ISO | US |
Name | Merck & Co., Inc | ISIN | DE0006599905 |
Exchange | NYSE | CUSIP | 589331107 |
Currency code | USD | Sector | Healthcare |
Currency name | US Dollar | Full-time employees | 71000 |
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; Transcenta Holding Ltd.; and Janux Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Steps to owning and managing Kodak shares from Australia.
Steps to owning and managing Sorrento Therapeutics shares from Australia.
Steps to owning and managing Marathon Patent Group shares from Australia.
Steps to owning and managing Kandi Technologies shares from Australia.
Steps to owning and managing Taoping shares from Australia.
Steps to owning and managing American Airlines shares from Australia.
Steps to owning and managing MGM Resorts shares.
Steps to owning and managing Precipio shares.
Steps to owning and managing ADT shares from Australia.
Steps to owning and managing DiamondPeak Holdings shares from Australia.